Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system.

Patient Preference and Adherence
Chandra Kailasam, David Cahill

Abstract

The levonorgestrel-containing intrauterine system is an extremely effective, reversible and safe form of long-term yet reversible birth control. In view of its efficacy, it is a safer alternative to permanent contraceptive methods such as sterilization. It is especially useful in situations where use of estrogen-containing contraceptives is contraindicated. While menstrual disturbances are a common side effect, proper counseling improves compliance. In addition to its contraceptive effect, the levonorgestrel intrauterine system offers potential therapeutic benefits in other clinical contexts, including menorrhagia, symptomatic fibroids, endometriosis, and endometrial protection.

References

May 1, 1991·Contraception·B JonssonP Eneroth
Apr 1, 1996·Baillière's Clinical Obstetrics and Gynaecology·V Odlind
Oct 5, 2001·Gynecologic and Obstetric Investigation·I BonachoM I Gómez-Besteiro
Mar 26, 2002·Climacteric : the Journal of the International Menopause Society·F E Riphagen
Jun 1, 2002·Obstetrics and Gynecology·Tiina BackmanMarkku Koskenvuo
Oct 18, 2002·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·P InkiJ Paavonen
Jan 30, 2004·American Journal of Obstetrics and Gynecology·Tiina BackmanMarkku Koskenvuo
Oct 4, 2005·Obstetrics and Gynecology·Tiina BackmanMarkku Koskenvuo
Dec 6, 2005·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Rajesh VarmaJanesh K Gupta
Feb 14, 2006·Contraception·K Van HoudenhovenG A J Dunselman
Apr 21, 2006·The Cochrane Database of Systematic Reviews·J MarjoribanksC Farquhar
Apr 22, 2006·Contraception·Catherine d'Arcangues
Mar 16, 2007·Archives of Gynecology and Obstetrics·Helen BudimanErnst R Weissenbacher
May 15, 2007·Best Practice & Research. Clinical Obstetrics & Gynaecology·Olav Istre, Erik Qvigstad
May 29, 2007·Contraception·Sarah Prager, Philip D Darney
May 29, 2007·Contraception·Rezan A Kadir, Claudia Chi
May 29, 2007·Contraception·Andrew M Kaunitz
May 29, 2007·Contraception·David A GrimesKenneth F Schulz
May 29, 2007·Contraception·Anja Guttinger, Hilary O D Critchley
Aug 21, 2007·Fertility and Sterility·Xuan Bich TrinhPeter A van Dam

❮ Previous
Next ❯

Citations

Jan 3, 2015·Climacteric : the Journal of the International Menopause Society·H Depypere, P Inki
Jul 17, 2015·Journal of Clinical Ultrasound : JCU·Carla Maria Araujo AndradeCristina Aparecida Falbo Guazzelli
Mar 21, 2017·Psychoneuroendocrinology·Jurate AleknaviciuteSteven A Kushner
Mar 7, 2017·Thrombosis Research·Joanna Davies, Rezan A Kadir
Nov 24, 2018·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·J BitzerC N Soares
Mar 8, 2019·JAAPA : Official Journal of the American Academy of Physician Assistants·Talia Sierra
Jun 21, 2019·British Journal of Clinical Pharmacology·Claire LangladeUNKNOWN French Network of Pharmacovigilance Centres
Jul 9, 2020·Journal of Clinical Medicine·Magdalena ZgliczynskaKatarzyna Kosinska-Kaczynska
Mar 27, 2019·JAAPA : Official Journal of the American Academy of Physician Assistants·Talia Sierra
May 29, 2021·Clinical Breast Cancer·Fabio R SilvaMaria Inês da Rosa
Jun 22, 2021·Liver International : Official Journal of the International Association for the Study of the Liver·Sophie E AapkesJoost P H Drenth
Oct 2, 2021·Experimental and Therapeutic Medicine·Aurelian Mihai GhitaAna Cristina Ghita

❮ Previous
Next ❯

Methods Mentioned

BETA
contraception
X-ray
hysterectomy
hormone replacement therapy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Acta Obstetricia Et Gynecologica Scandinavica
Oskari Heikinheimo, Kristina Gemzell-Danielsson
Drugs of Today
C Jay McGavigan, I T Cameron
European Review for Medical and Pharmacological Sciences
B ChattopdhyayP S Chakravarty
British Journal of Obstetrics and Gynaecology
J W Barrington, P Bowen-Simpkins
© 2022 Meta ULC. All rights reserved